Guidance for Obagi Medical Products, Inc. (OMPI)

Period Range Estimate Revenue Range Revenue Estimate Target Details
2013 $0.80 – $0.84 $0.88 $126.00M – 130.00M $129.20M Lowered Details
2012 $0.58 – $0.62 $0.60 $119.00M – 124.00M $122.94M = Maintained Details
2012 $0.89 – $0.91 $0.89 N/A N/A = Maintained Details
2012 $0.62 – $0.63 $0.61 $119.50M – 120.50M $121.93M = Maintained Details
Q4 2012 $0.12 – $0.13 $0.15 $29.00M – 30.00M $31.80M = Maintained Details
Q3 2012 $0.12 – $0.13 $0.14 $27.50M – 28.50M $30.02M = Maintained Details
Q1 2012 $0.10 – $0.11 $0.20 $27.00M – 29.00M $28.05M = Maintained Details
2011 $0.87 – $0.91 $0.83 $119.00M – 122.00M $121.00M = Maintained Details
2011 $0.78 – $0.78 $0.89 $114.00M – 116.00M $120.60M = Maintained Details
Q3 2011 $0.16 – $0.17 $0.18 $27.00M – 28.50M $28.00M = Maintained Details
Q2 2011 $0.15 – $0.17 $0.23 $26.50M – 28.00M $30.67M = Maintained Details
Q1 2011 $0.11 – $0.12 $0.12 $26.00M – 27.00M $28.00M = Maintained Details